SHCBP1 and neoplasm: Therefore, the role of Rh7 may be through interfering with the formation of SHCBP1-β-catenin complex, affecting the nuclear translocation of β-catenin and the activation of Wnt signaling pathway, which provides a potential molecular mechanism for Rh7 as an anti-tumor agent.